Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged additional equity shares as margin for financial assistance, according to a regulatory disclosure filed on April 9, 2026. The pledge was created on March 30, 2026, in favor of Ashika Credit Capital Limited to address shortfall in security cover requirements.

Share Pledge Details

The latest encumbrance involves 6.50 lakh equity shares, representing 0.34% of the company's total share capital. This pledge was created as additional margin to cover shortfall in security cover with respect to financial assistance obtained by the target company.

Promoter Shareholding Position

Following this transaction, Dandekar's total encumbered shareholding has increased significantly. The promoter maintains a substantial stake in the company while using a major portion as collateral for financial arrangements.

Regulatory Compliance Framework

The disclosure was made in compliance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that while the encumbered shares represent more than 50% of the promoter's shareholding, they constitute less than 20% of the company's total share capital.

Ashika Credit Capital Limited, the entity in whose favor the shares have been pledged, operates as a non-banking financial company (NBFC). The pledge arrangement does not involve any debt instruments such as debentures, commercial paper, or certificates of deposit.

Purpose and Utilization

The encumbrance serves as additional margin pledge for covering shortfall in security cover related to financial assistance obtained by Camlin Fine Sciences. This indicates the pledge is being utilized for the benefit of the listed company rather than for personal use by the promoter. The arrangement helps ensure adequate collateral coverage for the company's financial assistance requirements, demonstrating the promoter's commitment to supporting the company's operational needs.

Camlin Fine Sciences Limited has submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 to stock exchanges. The certificate pertains to the quarter ended March 31, 2026, and was filed with both BSE Limited and National Stock Exchange of India Limited on April 8, 2026.

Regulatory Compliance Submission

The company submitted the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and VP Legal Rahul Sawale signed and submitted the compliance document to ensure adherence to regulatory requirements.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the Registrar and Share Transfer Agent for Camlin Fine Sciences Limited. The registrar issued the confirmation certificate on April 3, 2026, which was subsequently forwarded to the stock exchanges.

Certificate Confirmations

The registrar confirmed several key compliance aspects for the quarter:

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were confirmed or rejected within prescribed timelines
• Security certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the register of members as registered owners

Company Information

The submission ensures Camlin Fine Sciences Limited maintains compliance with SEBI depositories regulations, confirming proper handling of securities dematerialisation processes during the quarter ended March 31, 2026.